Product NDC: | 45802-263 |
Proprietary Name: | Clindamycin Phosphate |
Non Proprietary Name: | Clindamycin Phosphate |
Active Ingredient(s): | 10 mg/mL & nbsp; Clindamycin Phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-263 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065049 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060531 |
Package NDC: | 45802-263-93 |
Package Description: | 69 APPLICATOR in 1 JAR (45802-263-93) > 1 mL in 1 APPLICATOR |
NDC Code | 45802-263-93 |
Proprietary Name | Clindamycin Phosphate |
Package Description | 69 APPLICATOR in 1 JAR (45802-263-93) > 1 mL in 1 APPLICATOR |
Product NDC | 45802-263 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin Phosphate |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 20060531 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |